June 28, 2022
Contrast media shortage reveals cracks in supply chain
May 2022 saw a critical shortage of the iodinated contrast medium (ICM) iohexol that extended well into June because of a COVID-19-related shutdown of a GE Healthcare plant in Shanghai, China, that interrupted the manufacture of ICM. According to the American College of Radiology, contrast media were added to the US Food and Drug Administration (FDA) drug shortage list on May 9.
Free Daily News
- Ambulatory general surgery safe for older adults when patients are carefully selected
- Outpatient artificial disc replacement proves safe, efficient, game-changing for spine surgery
- Study identifies risk factors for PE and DVT after ambulatory surgery
- Surgical patients see better outcomes but face longer hospital stays, AHA and Vizient report finds
- Study shows new nurses need a year to be ready for independent practice
- FDA flags device recalls while clearing new technologies for surgery, critical care
- Back to Business: Budgeting for Sustainable Staffing Models in the OR
- Healthcare job gain in August offset by losses in federal government, other industries
- AHA study: HOPD Medicare patients are poorer, sicker, more rural than those seen in physician offices
- ACS, Lifesaving Technologies launch nationwide effort to expand bleeding control readiness
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement